Correlation Between Histopathology and Chemotherapy Response in Epithelial Ovarian Tumors
Histopathological subtype is a major determinant of response to neoadjuvant carboplatin-paclitaxel in epithelial ovarian carcinoma. Integrating RECIST response, CA-125 kinetics, CRS, and residual disease provides a pragmatic, histology-informed framework for treatment planning, particularly in settings where molecular profiling is limited.
Authors
- T Sravanthi
- M Ramya
- M Srinivasulu
- Surekha Talasila
Institutions
- Gandhi Medical College & Hospital (IN)
- MNJ Institute Of Oncology and Regional Cancer Centre (IN)
- Employees State Insurance Post Graduate Institute of Medical Sciences and Research (IN)
- Employees' State Insurance Model Hospital (IN)
Publication Details
- Journal
- Cureus
- Published
- 2026-01-08
- DOI
- https://doi.org/10.7759/cureus.101088
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00